FACTFLOW

Monday, 11 May 2026 · Global Edition · Updated 03:25 CST
Business

Ascendis Pharma wins FDA approval for navepegritide for achondroplasia

Business

Oil jumps as market sees rising risk of U.S.-Iran conflict

Business

Delta continues fleet renewal, ordering another 34 Airbus jets

Business

Via targets 25%+ revenue growth and first profitable quarter in Q4 2026 amid AI-driven product expansion

Business

Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix

Business

ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing

Business

RLJ Lodging Trust targets 0.5%–3% RevPAR growth for 2026 amid urban market momentum and capital allocation flexibility

Business

Hawaiian Electric signals $550M–$700M capex for 2026 as wildfire settlements near final approval

Business

Gold, silver cap historic month with best-ever dollar gains; U.S.-Iran tensions in focus

Business

Greencastle to raise up to $200,000 in private placement, names new CEO

Business

Calumet targets MaxSAF 150 expansion and $1–$2/gallon SAF contract premiums as operational gains drive leverage reduction

Business

Defence Therapeutics to raise up to $11 million in private placement

Business

Trump Media & Technology Group reports FY25 results

Business

DiamondRock targets 1–3% RevPAR growth and $1.09–$1.16 FFO per share in 2026 as it plans capital recycling and disciplined CapEx

Business

Energy Fuels outlines uranium production guidance of up to 2.5M pounds in 2026 while expanding rare earth capabilities

Prev 1 285 286 287 288 289 290 291 396 Next